By
Adrianne Appel2022-10-20T20:17:00
Seven members of corporate boards resigned after the Antitrust Division of the Department of Justice (DOJ) flagged their situations as potential violations of the Clayton Act.
Assistant Attorney General Jonathan Kanter, head of the Antitrust Division, put companies on notice during a speech delivered in April that he intended to begin ramping up enforcement of Section 8 of the Clayton Act, which prohibits directors and officers from sitting on boards of competing businesses.
The agency warned again in a press release Wednesday the seven resignations were just the first action “in a broader review of potentially unlawful interlocking directorates.”
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2024-04-02T00:04:00Z By Kyle Brasseur
Two directors on the board at media giant Warner Bros. Discovery resigned after the Department of Justice raised antitrust concerns regarding their similar positions on the board of Charter Communications.
2023-03-09T21:13:00Z By Adrianne Appel
Five corporate board members resigned after being flagged by the Department of Justice for potentially violating the antitrust provisions of the Clayton Act.
2023-02-06T19:20:00Z By Adrianne Appel
The Department of Justice announced the withdrawal of three guidance documents related to mergers and antitrust in healthcare, after labeling the policy statements “outdated” and “overly permissive.”
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud